Brind.

Entities / Company

Puma Biotechnology (United States).

company in Los Angeles, United States

Seen in 11 reportsLast reported May 20

Reports this week: 0
Active events: 0
Connections: 10

What's happening

Gone quiet

No new reports in 90+ days

Barclays maintained a Sell rating on Puma Biotechnology (PBYI), noting that Trump-era tariffs and onshoring trends benefit AI stocks.

Some support1 report
Puma Biotechnology achieved a Value Score of A as of August 12, 2025.

Some support1 report

History

Events by the month they began

June 2026

2 events